N-Cadherin, a Novel Prognostic Biomarker, Drives Malignant Progression of Colorectal Cancer

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2015.3687
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer
Oncology
2017English

Finding a New Prognostic Biomarker for Metastatic Colorectal Cancer

Journal of the Korean Society of Coloproctology
2012English

NOTCH4 Is a Novel Prognostic Marker That Correlates With Colorectal Cancer Progression and Prognosis

Journal of Cancer
Oncology
2018English

Disseminated Tumour Cells as a Prognostic Biomarker in Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Soluble Neural-Cadherin as a Novel Biomarker for Malignant Bone and Soft Tissue Tumors

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

Septin-9: A Novel Biomarker for Colorectal Cancer Screening

International Surgery Journal
2019English

Decreased Expression of Chromodomain Helicase DNA-binding Protein 9 Is a Novel Independent Prognostic Biomarker for Colorectal Cancer

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2018English

SMAGP a Novel Biomarker of Cervical Cancer Development and Progression [Erratum]

OncoTargets and Therapy
OncologyPharmacology
2020English

Upregulation of WEE1 Is a Potential Prognostic Biomarker for Patients With Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy